Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc owns 1 orange book drug protected by 1 US patent Given below is the list of Teva Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
Active


Teva Pharms Inc's Family Patents


Family Patents



Recently granted tentative Approvals to Teva Pharms Inc

These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Teva Pharms Inc's portfolio.

Generic tentative approvals

Drug Name Active Ingredient Submission Type Submission Category Submission Date
Ribavirin Ribavirin ORIG-1
Orig = Original submission
Suppl = Supplement submission
Number = submission sequence
(Not Available) 28 Mar, 2011
Escitalopram Oxalate Escitalopram Oxalate ORIG-1
Orig = Original submission
Suppl = Supplement submission
Number = submission sequence
(Not Available) 26 Jul, 2006
Modafinil Modafinil ORIG-1
Orig = Original submission
Suppl = Supplement submission
Number = submission sequence
(Not Available) 16 Dec, 2005

Explore deeper patents analysis

Teva Pharms Inc Drug List

Given below is the complete list of Teva Pharms Inc's drugs and the patents protecting them.


1. Alvaiz

Alvaiz is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
(12 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvaiz's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

Teva complies with FTC regarding Orange Book entries - BioWorld

12 Dec, 2025

An All-Inclusive Guide to Generic Medications - openPR.com

11 Dec, 2025

Teva Eliminates More than 200 Incorrect Patent Registrations Following FTC Pressure

10 Dec, 2025

Teva eliminates more than 200 incorrect patent entries following pressure from the US Federal Trade Commission | MLex

10 Dec, 2025

See More